Alpha Omega Wealth Management’s Array Biopharma Inc ARRY Stock Holding History

Alpha Omega Wealth Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-661	Closed	-$31K	–	624
2019 Q2	$31K	Hold	661	–	–	0.01%	310
2019 Q1	$16K	Buy	+661	New	+$13.8K	0.01%	380

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Alpha Omega Wealth Management's ARRY Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 661 shares — an estimated $31K sold.

Alpha Omega Wealth Management first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $31K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 661 Array Biopharma Inc shares in Q3 2019, an estimated $31K.
Alpha Omega Wealth Management first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
Alpha Omega Wealth Management's Array Biopharma Inc position peaked at $31K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.